Fungal endophytes: A promising frontier for breast cancer treatment

FHS
July 10, 2024
4:53 am

A recent study in Heliyon highlights the potential of fungal endophytes in developing novel anti-cancer agents, specifically targeting breast cancer therapy.

Eli Lilly says its weight loss drug Zepbound outperformed Wegovy in a study

Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo Nordisk, in a head-to-head

December 4, 2024

The 3 Predictors of the Intensity of a Psychedelic Experience

What variables, if any, can predict the intensity of a psychedelic mystical experience? Perhaps a better question to ask is: why would identifying these

October 21, 2023

Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone

SAN DIEGO — Cardiovascular medications were better optimized for patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) following a multifaceted intervention involving

June 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.